Researchers at Stanford are advancing a new treatment for heart failure based on the transfer of mitochondria-rich extracellular vesicles from iPSC-derived cardiomyocytes. Heart failure is the leading cause of hospital admission in the U.S.
Researchers at Stanford have developed reactive oxygen species (ROS) sensing nanoparticles (NP) that can amplify Raman fingerprint signals and detect ROS changes.
The Hong Neurotechnology Lab at Stanford University developed ultrasound-activated nanoscopic light emitters (mechanoluminescent nanoparticles) that are delivered via the blood stream, unlike conventional optogenetics approaches that require invasive fiber optic implants.
Researchers in Prof. A.C. Matin's laboratory have developed a versatile exosome (extracellular vesicle, "EV") drug delivery platform that can selectively target therapeutic agents to tumors or other tissues that overexpress extracellular receptors.
Stanford researchers have developed a new class of materials that enable new strategies for the efficient delivery of messenger RNA (mRNA) into cells and animals. The delivery materials are easily prepared (2 steps), stable and readily tuned.
Researchers at Stanford University and SLAC National Accelerator Laboratory have developed a new coating design which makes lithium metal batteries stable and promising for further development.
Stanford researchers have developed a high-performance, ultrafast, thermoresponsive polymer that can act as a circuit breaker to prevent fires in next-generation high-energy-density batteries by rapidly and reversibly turning off when overheated.
We created a transgenic mouse on the FVB background in which the transgene is comprised of a strong constitutive promoter (CAG) driving expression of a dual reporter gene (luciferase and GFP). We called the original FVB mouse L2G85.
Researchers at Stanford and their colleagues have developed compositions and methods for producing improved lipid nanodiscs that enable more effective studies of membrane proteins. Traditionally, scientists have studied proteins using x-ray crystallography.
Stanford researchers in the Dai Lab have developed the first ultra-bright cubic-phase erbium-based rare-earth nanoparticles (α-ErNPs) with down-shifting luminescence at ~ 1600 nm for in vivo NIR-IIb (1500-1700 nm) imaging with deep penetration and high clarity.
Researchers at Stanford have developed a targeted delivery system using carbon nanotubes to specifically deliver cardiovascular drugs to treat atherosclerosis. A feature of atherosclerotic plaque is the accumulation of apoptotic cells.